SEHK:6667Healthcare
Mega Genomics (SEHK:6667) Margin Improvement Challenges Longstanding Bearish Narratives
Mega Genomics (SEHK:6667) has reported its FY 2025 first half results with revenue of ¥81.3 million and basic EPS of ¥0.13, set against a trailing twelve month revenue of ¥138.2 million and EPS of ¥0.17 as earnings grew 10.8% over the past year. The company has seen revenue move from ¥107.3 million and EPS of ¥0.18 in the first half of 2024 to ¥81.3 million and ¥0.13 in the first half of 2025. Over the last 12 months, margins improved to a 25.6% net profit level, giving investors a clearer...